This early-stage study tests a new medicine called DR-01 in 81 adults with alopecia areata (patchy hair loss) or vitiligo (white patches on skin). The main goals are to check safety and see if the drug can improve hair regrowth or skin color. Participants are randomly assigned to…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC